Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Taiwan Liposome Company, Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Taiwan Liposome Company, Ltd. - Product Pipeline Review - 2014', provides an overview of the Taiwan Liposome Company, Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Taiwan Liposome Company, Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Taiwan Liposome Company, Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Taiwan Liposome Company, Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Taiwan Liposome Company, Ltd.'s pipeline products Reasons to buy - Evaluate Taiwan Liposome Company, Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Taiwan Liposome Company, Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Taiwan Liposome Company, Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Taiwan Liposome Company, Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Taiwan Liposome Company, Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Taiwan Liposome Company, Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Taiwan Liposome Company, Ltd. Snapshot 5 Taiwan Liposome Company, Ltd. Overview 5 Key Information 5 Key Facts 5 Taiwan Liposome Company, Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Taiwan Liposome Company, Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Taiwan Liposome Company, Ltd. - Pipeline Products Glance 12 Taiwan Liposome Company, Ltd. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Taiwan Liposome Company, Ltd. - Early Stage Pipeline Products 14 IND/CTA Filed Products/Combination Treatment Modalities 14 Preclinical Products/Combination Treatment Modalities 15 Taiwan Liposome Company, Ltd. - Drug Profiles 16 TLC-388 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 dexamethasone SR 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 bupivacaine 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 TLC-599 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 vinorelbine 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Taiwan Liposome Company, Ltd. - Pipeline Analysis 22 Taiwan Liposome Company, Ltd. - Pipeline Products by Target 22 Taiwan Liposome Company, Ltd. - Pipeline Products by Route of Administration 23 Taiwan Liposome Company, Ltd. - Pipeline Products by Molecule Type 24 Taiwan Liposome Company, Ltd. - Pipeline Products by Mechanism of Action 25 Taiwan Liposome Company, Ltd. - Recent Pipeline Updates 26 Taiwan Liposome Company, Ltd. - Dormant Projects 27 Taiwan Liposome Company, Ltd. - Locations And Subsidiaries 28 Head Office 28 Other Locations & Subsidiaries 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30
List of Tables Taiwan Liposome Company, Ltd., Key Information 5 Taiwan Liposome Company, Ltd., Key Facts 5 Taiwan Liposome Company, Ltd. - Pipeline by Indication, 2014 7 Taiwan Liposome Company, Ltd. - Pipeline by Stage of Development, 2014 8 Taiwan Liposome Company, Ltd. - Monotherapy Products in Pipeline, 2014 9 Taiwan Liposome Company, Ltd. - Partnered Products in Pipeline, 2014 10 Taiwan Liposome Company, Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11 Taiwan Liposome Company, Ltd. - Phase II, 2014 12 Taiwan Liposome Company, Ltd. - Phase I, 2014 13 Taiwan Liposome Company, Ltd. - IND/CTA Filed, 2014 14 Taiwan Liposome Company, Ltd. - Preclinical, 2014 15 Taiwan Liposome Company, Ltd. - Pipeline by Target, 2014 22 Taiwan Liposome Company, Ltd. - Pipeline by Route of Administration, 2014 23 Taiwan Liposome Company, Ltd. - Pipeline by Molecule Type, 2014 24 Taiwan Liposome Company, Ltd. - Pipeline Products by Mechanism of Action, 2014 25 Taiwan Liposome Company, Ltd. - Recent Pipeline Updates, 2014 26 Taiwan Liposome Company, Ltd. - Dormant Developmental Projects,2014 27 Taiwan Liposome Company, Ltd., Subsidiaries 28
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.